Follow-The-Filings

Security

Atyr Pharma Inc. · COM NEW

Equity holders as of 2026 Q1 (each manager’s latest book)

8 owners 5 new max 0.0% (Vanguard Group Inc.)

owners 8
max % 0.0%
tracked value $6M
qoq N 5 R 2

holders

sorted by % of portfolio · long equity only

manager % port activity shares value history
Vanguard Group Inc. 2025 Q4 stale 0.0% Reduce 0.00 pp 4,961,871 $4M hist
Israel Englander - Millennium Management LLC 2026 Q1 0.0% New 0.0% 1,641,246 $1M hist
Cliff Asness - Aqr Capital Management LLC 2026 Q1 0.0% Reduce 0.00 pp 496,018 $387 hist
Two Sigma Investments, LP 2025 Q4 stale 0.0% Exit 0.00 pp 454,443 $356 hist
Marshall Wace - Marshall Wace, LLP 2026 Q1 0.0% New 0.0% 138,118 $108 hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% New 0.0% 47,372 $37 hist
Renaissance Technologies LLC 2026 Q1 0.0% New 0.0% 40,522 $32 hist
Dmitry Balyasny - Balyasny Asset Management L.P. 2026 Q1 0.0% New 0.0% 10,330 $8 hist

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $353,000 $235,000 $190,000
Gross profit
Gross margin
Net income -$50.39M -$64.02M -$74.12M
Net margin * -14274.5% -27243.8% -39009.5%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $102.99M $81.95M $80.24M
Total non-current assets * $17.66M $14.88M $12.77M
Total assets $120.65M $96.83M $93M
Total current liabilities $16.42M $14.97M $15.15M
Total non-current liabilities
Total equity $90.66M $70.02M $67.48M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$33.22M -$69.12M -$61.99M
Cash from investing -$20.13M $17.23M -$5.05M
Cash from financing $66.23M $39.86M $66.01M
Net change in cash $12.88M -$12.02M -$1.03M

ownership over time

filing count by report period · click a bar for that quarter’s holders